PMK urges govt. to try Siddha medicine for COVID-19

Plea of National Institute of Siddha should not be ignored, says Anbumani Ramadoss

Updated - June 18, 2020 12:15 pm IST

Published - June 18, 2020 11:46 am IST - CHENNAI

Anbumani Ramadoss. File Photo: B. Velankanni Raj velankanni Raj

Anbumani Ramadoss. File Photo: B. Velankanni Raj velankanni Raj

The PMK on Thursday urged the State government to consider Siddha medicine for treatment of COVID-19.

In a statement, party leader Anbumani Ramadoss cited the claims made by the National Institute of Siddha that it had successfully treated 160 COVID-19 patients in Chennai within five days. The Institute had requested the government to hand over COVID-19 Care Centres in the city to facilitate Siddha doctors to commence treatment.

Dr.Ramadoss claimed that in 2009, Kabasura Kudineer prepared by the Institute helped in containing the spread of swine flu and in 2012 the then Chief Minister Jayalalithaa had requested public to use Nilavembu Kudineer prepared by the Institute to prevent dengue.

“The request of the National Institute of Siddha cannot be ignored and should be considered by the State government,” he added.

“When medicines have not yet been discovered for COVID-19, the emerging opportunities should be utilised. If the treatment offered by the Siddha Institute turns successful, it would give pride and recognition for the State,” he said.

The State government must tie up with the Institute and consider handing over selective number of beds to start with.

“Based on treatment progress and wish of the patients, the number of beds to be handed over can be increased,” the PMK leader suggested.

0 / 0
Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in

Comments

Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.